Every material Form 8-K Xylem filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Xylem reported third-quarter 2026 revenue of $2.2 billion, down 3% on a reported basis and flat organically, while reported earnings per share rose 34% to $1.25. The company lowered its full-year 2026 adjusted EPS guidance to $5.40-$5.45 from $5.55-$5.70 and cut its revenue forecast to a 1% decline from a prior 2% gain, and it said it intends to divest Applied Water International and Specialty Flow Control and reorganize into three segments in 2027.
Q3 2026 revenue was $2.2 billion, down 3% on a reported basis; adjusted EPS was $1.44, up 5%, and reported EPS was $1.25, up 34%
Full-year 2026 revenue is now expected at about $8.95 billion, down 1% reported, versus prior guidance of up 2%
Full-year 2026 adjusted EPS guidance was lowered to $5.40-$5.45 from $5.55-$5.70
Executive Hayati Yarkadas will cease to be an executive officer on January 1, 2027 and will lead the planned divestitures, with a $1.2 million success incentive tied to their closing
Xylem entered into a new five-year, $1.5 billion senior unsecured revolving credit facility on September 8, 2026, and terminated its $1.0 billion facility from March 2023 at the same time. The company says the new facility will fund working capital and general corporate purposes, and no borrowings were outstanding on the filing date.
New facility: up to $1.5 billion, five years, available in U.S. dollars and Euros, with accordion increases of up to $500 million to a $2.0 billion maximum
Terminated 2023 facility: $1.0 billion, dated March 1, 2023, with citibank, N.A. as administrative agent
No borrowings outstanding under the new agreement as of September 8, 2026; loans carry a leverage-based covenant on total debt to EBITDA
Xylem said CFO William Grogan will resign effective August 31, 2026 to pursue another opportunity, and Andrea van der Berg, currently SVP Finance for the Water Infrastructure segment, will become CFO on September 1, 2026. Xylem also reaffirmed its third-quarter and full-year 2026 guidance issued July 28, 2026, which matters to shareholders because it signals no change to the outlook alongside the finance leadership change.
Grogan remains employed through September 13, 2026 to support the transition.
Van der Berg's annual base salary is $675,000, with an AIP target of 80% of base salary.
Van der Berg receives a one-time 2026 LTIP award with a grant date value of $787,500, and a new LTIP target award of $1,750,000.
Xylem reaffirmed its third-quarter and full-year 2026 guidance issued July 28, 2026.
Xylem expanded its Board of Directors from 9 to 10 members and appointed D. Christian Koch to fill the new seat, effective immediately on August 13, 2026. The Board determined Koch is independent, and he also joined the Leadership Development and Compensation Committee and the Nominating and Governance Committee. Koch currently serves as Chairman, President and Chief Executive Officer of Carlisle Companies Incorporated, and the filing states he will receive standard non-employee director compensation, prorated for the current term.
Board size increased from 9 to 10 directors; Koch appointed to fill the vacancy effective August 13, 2026
Koch joins the Leadership Development and Compensation Committee and the Nominating and Governance Committee
Board determined Koch is independent under NYSE listing standards and SEC rules
Koch is Chairman, President and CEO of Carlisle Companies Incorporated; compensation follows the 2026 Proxy Statement filed March 20, 2026, prorated for the current term
Xylem reported second-quarter 2026 revenue of $2.3 billion, up 2% on a reported basis, and net income attributable to Xylem of $263 million, or $1.11 per share, up 19%. The company raised its full-year adjusted EPS guidance to $5.55 to $5.70 from $5.35 to $5.60, but lowered its full-year revenue growth forecast to about 2% from 2% to 3%.
Q2 2026 adjusted EPS was $1.46, up 16%; orders were $3.1 billion, up 42% on a reported basis
Full-year 2026 adjusted EPS guidance raised to $5.55 to $5.70 from $5.35 to $5.60
Full-year 2026 revenue forecast of about $9.2 billion, up about 2% reported, versus 2% to 3% previously guided
Q2 adjusted EBITDA margin was 23.3%, up 150 basis points year over year
Xylem completed a $1 billion public offering of two series of senior unsecured notes on May 29, 2026. The company plans to use the 2033 notes' proceeds to repay its $500 million 3.250% notes due November 1, 2026, and the 2036 proceeds to fund eligible blue projects, which adds debt that shareholders will need to see serviced.
$500 million of 5.200% Senior Notes due June 1, 2033
$500 million of 5.450% Senior Blue Notes due June 1, 2036
Proceeds from the 2033 notes intended to repay $500 million of 3.250% notes maturing November 1, 2026
Interest payable semiannually on June 1 and December 1, starting December 1, 2026
Xylem reported first-quarter 2026 revenue of $2.1 billion, up 3% on a reported basis but flat organically, and diluted EPS of $0.79, up 14%. Adjusted EPS was $1.12, up 9%. The company raised its full-year 2026 reported revenue forecast to $9.2 to $9.3 billion, while keeping its adjusted EPS guidance of $5.35 to $5.60 unchanged.
Q1 2026 revenue of $2.1 billion, up 3% reported and flat organically; orders of $2.2 billion, up 3% reported
Diluted EPS $0.79 vs. $0.69 a year earlier; adjusted EPS $1.12 vs. $1.03
2026 revenue guidance raised to $9.2 to $9.3 billion, up 2% to 3% reported, from 1% to 3% previously
Adjusted EPS guidance of $5.35 to $5.60 kept in line with prior range; repurchases of common stock totaled $563 million in Q1
Xylem reported fourth-quarter and full-year 2025 results on February 10, 2026. Fourth-quarter revenue rose 6% to $2.4 billion and adjusted EPS rose 20% to $1.42, while GAAP EPS rose 2% to $1.37 because of higher restructuring and realignment costs. The company initiated 2026 guidance of $9.1 to $9.2 billion in revenue and $5.35 to $5.60 in adjusted EPS, and declared a first-quarter dividend of $0.43 per share, up 8%.
Q4 2025 revenue of $2.4 billion, up 6% reported and 4% organic; GAAP EPS $1.37, up 2%; adjusted EPS $1.42, up 20%
Full-year 2025 revenue of $9.0 billion, up 6%; GAAP diluted EPS $3.92, up 7%; adjusted EPS $5.08, up 19%
2026 guidance: revenue of $9.1 to $9.2 billion and adjusted EPS of $5.35 to $5.60
Quarterly dividend of $0.43 per share, up 8%, payable March 24, 2026 to holders of record as of February 24, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Xylem filing is on SEC EDGAR ↗. 8-K briefs of other companies →